Yair Levy, MD

Director of Hematologic Malignancies Research
Texas Oncology, Dallas, TX, USA

Poster(s):

• (PA-020) Real-world Outcomes Among Patients (Pts) with Relapsed or Refractory Multiple Myeloma (RRMM) Initiating Teclistamab (Tec) at a Large Community Oncology Center in the US
  Wednesday, September 17, 2025